IN8bio
INAB----
IN8bio (INAB)
IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
IN8bio Analyst Rating
View MoreForecast & Rating
Jun 4, 2026Price forecast
$6.25425.21%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · 6 hours ago
12 Health Care Stocks Moving In Thursday's After-Market Session
- PUBT · Jul 9 at 07:03 AM
IN8bio says JCO publication shows INB-200 trial doubles progression-free survival in repeat-dose glioblastoma patients
- Tip Ranks · May 7 at 06:29 PM
IN8bio Reports Q1 2026 Results and Shareholder Votes
- StockTitan · Apr 3 at 07:00 AM
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | INAB Stock News
